nodes	percent_of_prediction	percent_of_DWPC	metapath
Apraclonidine—Lofexidine—HTR1A—Parkinson's disease	0.0456	0.772	CrCbGaD
Apraclonidine—Clonidine—CYP2D6—Parkinson's disease	0.00787	0.133	CrCbGaD
Apraclonidine—Clonidine—ABCB1—Parkinson's disease	0.00562	0.0951	CrCbGaD
Apraclonidine—ADRA2A—Signaling by GPCR—PDYN—Parkinson's disease	0.000706	0.00075	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000703	0.000747	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000697	0.00074	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—RIT2—Parkinson's disease	0.000696	0.00074	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—HGF—Parkinson's disease	0.000695	0.000739	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—TAC1—Parkinson's disease	0.000692	0.000736	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR ligand binding—HTR2A—Parkinson's disease	0.000688	0.000731	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—EDN1—Parkinson's disease	0.000688	0.000731	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000687	0.00073	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—DRD1—Parkinson's disease	0.000679	0.000721	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000661	0.000703	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—GRK5—Parkinson's disease	0.00066	0.000702	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—DRD3—Parkinson's disease	0.000657	0.000699	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000656	0.000698	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—GRM5—Parkinson's disease	0.000656	0.000697	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—DDC—Parkinson's disease	0.00065	0.000691	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000647	0.000688	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—TAC1—Parkinson's disease	0.000646	0.000687	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—EDN1—Parkinson's disease	0.000639	0.000679	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—HTR1A—Parkinson's disease	0.000638	0.000678	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—DRD1—Parkinson's disease	0.000634	0.000674	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—GRM4—Parkinson's disease	0.000634	0.000674	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—SOD1—Parkinson's disease	0.00063	0.000669	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—TAC1—Parkinson's disease	0.000628	0.000668	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—DRD1—Parkinson's disease	0.000616	0.000655	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000614	0.000653	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—DRD3—Parkinson's disease	0.000614	0.000653	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—GSTA4—Parkinson's disease	0.000614	0.000653	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000614	0.000652	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—RIT2—Parkinson's disease	0.000609	0.000647	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—HTR2A—Parkinson's disease	0.000602	0.000639	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PENK—Parkinson's disease	0.000601	0.000639	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—MAG—Parkinson's disease	0.000601	0.000639	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—ABL1—Parkinson's disease	0.000601	0.000638	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000601	0.000638	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—IGF2—Parkinson's disease	0.000598	0.000636	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—DRD3—Parkinson's disease	0.000597	0.000634	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—HTR1A—Parkinson's disease	0.000596	0.000634	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—DRD2—Parkinson's disease	0.000594	0.000632	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—HTR7—Parkinson's disease	0.000594	0.000632	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—GRM4—Parkinson's disease	0.000592	0.000629	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—TAC1—Parkinson's disease	0.000587	0.000624	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—GRK5—Parkinson's disease	0.000577	0.000613	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—DRD1—Parkinson's disease	0.000576	0.000612	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000574	0.00061	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000573	0.000609	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—RIT2—Parkinson's disease	0.000566	0.000601	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—TAC1—Parkinson's disease	0.000565	0.000601	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—HGF—Parkinson's disease	0.000565	0.0006	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PENK—Parkinson's disease	0.000561	0.000597	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—MAG—Parkinson's disease	0.000561	0.000597	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—HTR2A—Parkinson's disease	0.000559	0.000594	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000558	0.000593	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—DRD3—Parkinson's disease	0.000558	0.000593	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000557	0.000592	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—HTR7—Parkinson's disease	0.000555	0.00059	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—DRD2—Parkinson's disease	0.000555	0.00059	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—DRD1—Parkinson's disease	0.000554	0.000589	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PLA2G6—Parkinson's disease	0.000553	0.000588	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PDYN—Parkinson's disease	0.00055	0.000584	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—MAOB—Parkinson's disease	0.000547	0.000582	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—HTR7—Parkinson's disease	0.00054	0.000574	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—DRD2—Parkinson's disease	0.00054	0.000574	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—DRD3—Parkinson's disease	0.000537	0.00057	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—GRK5—Parkinson's disease	0.000536	0.00057	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000533	0.000567	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—DDC—Parkinson's disease	0.000528	0.000561	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—TAC1—Parkinson's disease	0.000525	0.000558	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—HTR1A—Parkinson's disease	0.000521	0.000554	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000521	0.000553	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—GRM4—Parkinson's disease	0.000518	0.00055	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—GFAP—Parkinson's disease	0.000517	0.000549	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—DRD1—Parkinson's disease	0.000515	0.000547	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PDYN—Parkinson's disease	0.000513	0.000546	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—TAC1—Parkinson's disease	0.000513	0.000545	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—GRM5—Parkinson's disease	0.000511	0.000543	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—HTR7—Parkinson's disease	0.000504	0.000536	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—DRD2—Parkinson's disease	0.000504	0.000536	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—DRD1—Parkinson's disease	0.000503	0.000535	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000501	0.000533	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—DRD3—Parkinson's disease	0.000499	0.00053	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—GSTA4—Parkinson's disease	0.000499	0.00053	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—MAG—Parkinson's disease	0.000491	0.000522	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PENK—Parkinson's disease	0.000491	0.000522	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—DRD3—Parkinson's disease	0.000487	0.000518	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—DRD2—Parkinson's disease	0.000485	0.000516	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—HTR7—Parkinson's disease	0.000485	0.000516	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—HTR1A—Parkinson's disease	0.000484	0.000515	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—GFAP—Parkinson's disease	0.000483	0.000513	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—GRM4—Parkinson's disease	0.000481	0.000511	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—GRM5—Parkinson's disease	0.000477	0.000507	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—TAC1—Parkinson's disease	0.000477	0.000507	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—EDN1—Parkinson's disease	0.000476	0.000506	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—DRD1—Parkinson's disease	0.000468	0.000497	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000466	0.000495	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PENK—Parkinson's disease	0.000456	0.000485	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—MAG—Parkinson's disease	0.000456	0.000485	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000455	0.000484	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—DRD3—Parkinson's disease	0.000453	0.000481	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—DRD2—Parkinson's disease	0.000451	0.000479	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—HTR7—Parkinson's disease	0.000451	0.000479	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PLA2G6—Parkinson's disease	0.000449	0.000477	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PDYN—Parkinson's disease	0.000449	0.000477	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—FGF20—Parkinson's disease	0.000448	0.000476	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—EDN1—Parkinson's disease	0.000445	0.000472	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—MAOB—Parkinson's disease	0.000445	0.000472	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—DRD2—Parkinson's disease	0.000441	0.000468	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—HTR7—Parkinson's disease	0.000441	0.000468	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—ADORA2A—Parkinson's disease	0.000434	0.000462	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—EDN1—Parkinson's disease	0.000432	0.000459	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000423	0.000449	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—GFAP—Parkinson's disease	0.000422	0.000448	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—FGF20—Parkinson's disease	0.000419	0.000445	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—GRM5—Parkinson's disease	0.000417	0.000443	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PDYN—Parkinson's disease	0.000417	0.000443	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000416	0.000442	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—HTR7—Parkinson's disease	0.00041	0.000435	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—DRD2—Parkinson's disease	0.00041	0.000435	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—CYP2D6—Parkinson's disease	0.000407	0.000432	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—ADORA2A—Parkinson's disease	0.000406	0.000431	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—EDN1—Parkinson's disease	0.000404	0.000429	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—INSR—Parkinson's disease	0.000401	0.000426	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—CTGF—Parkinson's disease	0.000399	0.000424	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—GFAP—Parkinson's disease	0.000392	0.000417	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000389	0.000413	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—EDN1—Parkinson's disease	0.000389	0.000413	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—GRM5—Parkinson's disease	0.000388	0.000412	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—FGB—Parkinson's disease	0.000379	0.000403	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—HTR2A—Parkinson's disease	0.000378	0.000402	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—HTR1A—Parkinson's disease	0.000377	0.000401	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—INSR—Parkinson's disease	0.000375	0.000398	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—CYP2E1—Parkinson's disease	0.000372	0.000395	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—TAC1—Parkinson's disease	0.000371	0.000395	CbGpPWpGaD
Apraclonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.00037	0.000394	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—NQO1—Parkinson's disease	0.000368	0.000391	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—FGF20—Parkinson's disease	0.000366	0.000389	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—DRD1—Parkinson's disease	0.000364	0.000387	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—TH—Parkinson's disease	0.000363	0.000385	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—EDN1—Parkinson's disease	0.000361	0.000384	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—ADORA2A—Parkinson's disease	0.000355	0.000377	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—FGB—Parkinson's disease	0.000354	0.000376	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—HTR2A—Parkinson's disease	0.000353	0.000375	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—EDN1—Parkinson's disease	0.000353	0.000375	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—DRD3—Parkinson's disease	0.000353	0.000375	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—HTR1A—Parkinson's disease	0.000352	0.000374	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—CYCS—Parkinson's disease	0.000348	0.00037	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—TAC1—Parkinson's disease	0.000347	0.000369	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—DRD1—Parkinson's disease	0.00034	0.000361	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—HTR2A—Parkinson's disease	0.00034	0.000361	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—FGF20—Parkinson's disease	0.00034	0.000361	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—CYP2D6—Parkinson's disease	0.00033	0.000351	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—ADORA2A—Parkinson's disease	0.00033	0.00035	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—DRD3—Parkinson's disease	0.000329	0.00035	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—ADRBK1—Parkinson's disease	0.000329	0.00035	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—EDN1—Parkinson's disease	0.000328	0.000349	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—INSR—Parkinson's disease	0.000327	0.000348	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—CTGF—Parkinson's disease	0.000324	0.000345	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—HTR7—Parkinson's disease	0.000319	0.000339	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—DRD2—Parkinson's disease	0.000319	0.000339	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000316	0.000336	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—FGB—Parkinson's disease	0.000309	0.000329	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—HTR2A—Parkinson's disease	0.000309	0.000328	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—COMT—Parkinson's disease	0.000308	0.000328	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—HTR1A—Parkinson's disease	0.000308	0.000327	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—ADRBK1—Parkinson's disease	0.000308	0.000327	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—GSTP1—Parkinson's disease	0.000307	0.000326	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—MAOA—Parkinson's disease	0.000306	0.000325	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—INSR—Parkinson's disease	0.000304	0.000323	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—TAC1—Parkinson's disease	0.000303	0.000322	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—HMOX1—Parkinson's disease	0.000303	0.000322	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—CYP2E1—Parkinson's disease	0.000302	0.000321	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—NQO1—Parkinson's disease	0.000299	0.000318	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—DRD2—Parkinson's disease	0.000298	0.000317	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—HTR7—Parkinson's disease	0.000298	0.000317	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—DRD1—Parkinson's disease	0.000297	0.000316	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—TH—Parkinson's disease	0.000294	0.000313	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—ABCB1—Parkinson's disease	0.00029	0.000309	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—DRD3—Parkinson's disease	0.000288	0.000306	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—FGB—Parkinson's disease	0.000288	0.000306	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—HTR2A—Parkinson's disease	0.000287	0.000305	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—HTR1A—Parkinson's disease	0.000286	0.000304	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—CYCS—Parkinson's disease	0.000283	0.0003	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—GSTM1—Parkinson's disease	0.000282	0.0003	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—TAC1—Parkinson's disease	0.000282	0.000299	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—DRD1—Parkinson's disease	0.000276	0.000294	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—GPX1—Parkinson's disease	0.00027	0.000287	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	0.000269	0.000286	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—DRD3—Parkinson's disease	0.000268	0.000284	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IGF2—Parkinson's disease	0.000267	0.000284	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	0.00026	0.000277	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	0.00026	0.000277	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IGF1R—Parkinson's disease	0.000258	0.000275	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—EDN1—Parkinson's disease	0.000255	0.000271	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—COMT—Parkinson's disease	0.00025	0.000266	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—ADRBK1—Parkinson's disease	0.00025	0.000266	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IGF2—Parkinson's disease	0.00025	0.000265	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—GSTP1—Parkinson's disease	0.000249	0.000265	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—MTHFR—Parkinson's disease	0.000249	0.000265	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—MAOA—Parkinson's disease	0.000249	0.000264	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—HMOX1—Parkinson's disease	0.000246	0.000261	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—HTR7—Parkinson's disease	0.000242	0.000257	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—DRD2—Parkinson's disease	0.000242	0.000257	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IGF1R—Parkinson's disease	0.000241	0.000257	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—EDN1—Parkinson's disease	0.000238	0.000253	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—ABCB1—Parkinson's disease	0.000236	0.000251	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—NGF—Parkinson's disease	0.000235	0.000249	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—APOE—Parkinson's disease	0.000232	0.000247	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—GSTM1—Parkinson's disease	0.000229	0.000243	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—HTR2A—Parkinson's disease	0.000223	0.000237	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—GPX1—Parkinson's disease	0.000219	0.000233	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—NGF—Parkinson's disease	0.000219	0.000233	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	0.000218	0.000232	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	0.000211	0.000224	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—HTR2A—Parkinson's disease	0.000209	0.000222	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	0.000208	0.000222	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—APOE—Parkinson's disease	0.000208	0.000221	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	0.000203	0.000215	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—MTHFR—Parkinson's disease	0.000202	0.000215	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—INS—Parkinson's disease	0.000198	0.000211	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	0.000196	0.000208	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—APOE—Parkinson's disease	0.000194	0.000206	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	0.000194	0.000206	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	0.000192	0.000204	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—APOE—Parkinson's disease	0.000188	0.0002	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	0.000182	0.000194	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	0.000178	0.000189	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—INS—Parkinson's disease	0.000177	0.000189	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	0.00017	0.00018	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	0.000169	0.00018	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—INS—Parkinson's disease	0.000166	0.000176	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—INS—Parkinson's disease	0.000161	0.000171	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	0.000158	0.000167	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—INS—Parkinson's disease	0.000145	0.000154	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—INS—Parkinson's disease	0.000135	0.000143	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CASP3—Parkinson's disease	0.000132	0.00014	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—IL6—Parkinson's disease	0.000131	0.000139	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CASP3—Parkinson's disease	0.000123	0.000131	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—IL6—Parkinson's disease	0.000123	0.00013	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—MAPK8—Parkinson's disease	0.000121	0.000129	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—MAPK8—Parkinson's disease	0.000113	0.00012	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	0.000108	0.000115	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	0.000107	0.000114	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	0.0001	0.000106	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	9.96e-05	0.000106	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	9.91e-05	0.000105	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	9.21e-05	9.79e-05	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IL6—Parkinson's disease	7.75e-05	8.24e-05	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL6—Parkinson's disease	7.24e-05	7.69e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	6.33e-05	6.73e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	5.88e-05	6.25e-05	CbGpPWpGaD
